Global Bronchopulmonary Dysplasia Pipeline Review, H1 2020

    NEXT STORY
    Agios Announces FDA Clearance of Investigational New Drug Application for AG-946, a Next-Generation PKR Activator
    PREV STORY
    Helsinn announces European approval of the IV formulation of AKYNZEO® (fosnetupitant / palonosetron)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global E-Coli Partnering Deals and Agreements Directory 2019

    author_avatar
    NASDAQ Market News

    Iovance Biotherapeutics Enters into a Research Collaboration Focused on Hematologic Malignancies with The Ohio State University Comprehensive Cancer Center

    SAN CARLOS, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a ...

    author_avatar
    NASDAQ Market News

    Genkyotex Provides Corporate Update and Reports Cash Position at March 31, 2019

    author_avatar
    NASDAQ Market News